A three-dimensional MRI scan of the lungs can be used to monitor responses by cystic fibrosis (CF) patients to the approved…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Gene therapy to deliver a modified and better working version of the CFTR protein may be more effective in treating…
Porosome Therapeutics is seeking a U.S. patent that would cover its “radically new and distinctive” technology platform for the…
Taking high-dose vitamin D supplements during acute lung infections may help to improve bone health for people with cystic…
An international team of scientists has published new guidelines for how best to perform exercise testing in people with…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to BX004, a virus-based therapy that BiomX…
Treatment with Trikafta (ivacaftor/tezacaftor/elexacaftor) may help to ease a particular type of lung inflammation found in people with…
New grants awarded by the Cystic Fibrosis Foundation will help fund 10 programs that support people impacted by…
Scientists have synthesized a new compound that can boost the activity of the CFTR protein carrying the most common mutation…
Treatment with the CFTR modulator Kalydeco (ivacaftor) led to significant weight gain, suggesting better nutritional status, in  babies and…